S&P・Nasdaq 本質的価値 お問い合わせ

Ironwood Pharmaceuticals, Inc. IRWD NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
54/100
0/7 Pass
SharesGrow Intrinsic Value
$9.17
+127%
Analyst Price Target
$4.80
+18.8%

Ironwood Pharmaceuticals, Inc. (IRWD) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は MCCOURT Thomas A 1,898,838 株保有. その他の主要保有者には Shetzline Michael および Currie Mark G.

過去12ヶ月間にインサイダーは 40 件の取引を実施 IRWD 株式 — 20 件の買い (評価額 $62.26K) および 20 件の売り (評価額 $1.41M).

IRWD インサイダー保有状況

最大保有者
MCCOURT Thomas A
1,898,838 株
買い(12ヶ月)
20
$62.26K 評価額
売り(12ヶ月)
20
$1.41M 評価額
12ヶ月取引活動
買い 50%
売り 50%
インサイダー上位保有者
# 氏名 役職 保有株数 最終申告日 相対規模
1 Mccourt Thomas A Chief Executive Officer 1,898,838 2026-03-12
100%
2 Shetzline Michael SVP, CMO, Head-res&drug 658,037 2026-03-12
35%
3 Currie Mark G Director 613,419 2025-06-12
32%
4 John Minardo Chief Legal Officer 500,498 2026-03-12
26%
5 Mallon Mark Chief Executive Officer 470,605 2021-03-02
25%
6 Silver Ronald Principal Accounting Officer 416,570 2026-03-12
22%
7 Consylman Gina SVP, CFO & Treasurer 392,616 2021-03-30
21%
8 Gaskins Tammi L Chief Commercial Officer 350,350 2026-03-12
18%
9 Emany Sravan Kumar SVP, COO and CFO 309,572 2024-11-20
16%
10 Martini Gregory S. Chief Financial Officer 297,213 2026-03-12
16%
11 Davis Andrew SVP, Chief Business Officer 284,685 2024-11-20
15%
12 Gilbert Halley E Chief Admin Officer & SVP 265,991 2020-02-25
14%
13 Denner Alexander J Director 256,309 2026-03-17
13%
14 Owens Edward P Director 241,720 2021-06-04
13%
15 Dreyfus Andrew Director 228,313 2025-06-12
12%
16 Mchugh Julie Director 208,839 2025-06-12
11%
17 Duane Jon R Director 190,339 2025-06-12
10%
18 Shepard Jay Director 171,555 2025-06-12
9%
19 Kessler Marla L Director 165,883 2025-06-12
9%
20 Fanucci Marsha Director 132,663 2019-04-03
7%
最近の取引 (過去12ヶ月)
日付 氏名 役職 種類 株数 株価 価値
2026-03-17 Denner Alexander J Director 情報に基づく売り 5,800 $3.31 $19.2K
2026-03-13 Denner Alexander J Director RSU 付与(制限付株式) 4,451 - -
2026-03-10 Gaskins Tammi L Chief Commercial Officer RSU 付与(制限付株式) 136,612 - -
2026-03-10 Martini Gregory S. Chief Financial Officer RSU 付与(制限付株式) 136,612 - -
2026-03-10 John Minardo Chief Legal Officer RSU 付与(制限付株式) 136,612 - -
2026-03-10 Silver Ronald Principal Accounting Officer RSU 付与(制限付株式) 163,934 - -
2026-03-10 Shetzline Michael SVP, CMO, Head-res&drug RSU 付与(制限付株式) 136,612 - -
2026-03-10 Mccourt Thomas A Chief Executive Officer RSU 付与(制限付株式) 409,836 - -
2026-02-24 Gaskins Tammi L Chief Commercial Officer 情報に基づく売り 11,239 $3.66 $41.13K
2026-02-23 Gaskins Tammi L Chief Commercial Officer 情報に基づく売り 10,287 $3.81 $39.19K
2026-02-24 Martini Gregory S. Chief Financial Officer 情報に基づく売り 11,457 $3.66 $41.93K
2026-02-23 Martini Gregory S. Chief Financial Officer 情報に基づく売り 10,487 $3.81 $39.96K
2026-02-24 John Minardo Chief Legal Officer 情報に基づく売り 19,053 $3.66 $69.73K
2026-02-23 John Minardo Chief Legal Officer 情報に基づく売り 17,439 $3.81 $66.44K
2026-02-24 Silver Ronald Principal Accounting Officer 情報に基づく売り 12,621 $3.66 $46.19K
2026-02-23 Silver Ronald Principal Accounting Officer 情報に基づく売り 11,552 $3.81 $44.01K
2026-02-24 Shetzline Michael SVP, CMO, Head-res&drug 情報に基づく買い 17,012 $3.66 $62.26K
2026-02-23 Shetzline Michael SVP, CMO, Head-res&drug 情報に基づく売り 15,570 $3.81 $59.32K
2026-02-24 Mccourt Thomas A Chief Executive Officer 情報に基づく売り 103,526 $3.66 $378.91K
2026-02-23 Mccourt Thomas A Chief Executive Officer 情報に基づく売り 94,757 $3.81 $361.02K
2026-01-05 Silver Ronald Principal Accounting Officer 情報に基づく売り 35,416 $4.60 $162.91K
2025-12-15 Denner Alexander J 10 Percent Owner RSU 付与(制限付株式) 4,178 - -
2025-11-17 Gaskins Tammi L Chief Commercial Officer 情報に基づく売り 6,016 $3.32 $19.97K
2025-09-15 Denner Alexander J 10 Percent Owner RSU 付与(制限付株式) 11,718 - -
2025-08-11 Gaskins Tammi L Chief Commercial Officer 情報に基づく売り 1,316 $0.84 $1.11K
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る